FIELD: pharmaceutical technology. SUBSTANCE: compound Nω-(2-chloroethyl)-Nε-nitroso-L-homocitrulline or Nω-(2-chloroethyl)-Nω,ε-nitroso-L-homocitrulline is dissolved in solvent cooled to (+2)-(+5) C at ratio 1:25. Solvent consists of 15-25 g urea and additional components - 4-6 g polyvinylpyrrolidone (molecular mass is 12000-35000 Da) or dextran (molecular mass is 40000-60000 Da), 0.8-0.9 g glutamic acid, 5-6 g mannitol and 88-92 g water for injection. This invention relates to lyophilized form of new antitumor preparation nitrullin, derivative of nitrosoalkylureas, from alkylating compounds class. EFFECT: elimination of adverse effect at chemotherapy. 3 dwg
Title | Year | Author | Number |
---|---|---|---|
N-NITROSO-N-[(2-CHLOROETHYL)CARBAMOYL]-L- ORNITHINE | 2012 |
|
RU2503657C1 |
ANTITUMOR AGENT | 1980 |
|
SU1834006A1 |
METHOD OF PRODUCING SEPARATE N -NITROSO- N -[(2-CHLOROETHYL) CARBAMOYL]-L-LYSINE AND N -[(2-CHLOROETHYL)-N-NITROSOCARBAMOYL]-L-LYSINE | 2008 |
|
RU2408576C2 |
ANTITUMOR AGENT | 1996 |
|
RU2093158C1 |
METHOD OF PRODUCING N-NITROSO-N2-CHLOROETHYL)CARBAMOYL]-L-ORNITHINE | 2015 |
|
RU2601753C1 |
ANTITUMOR AGENT | 1998 |
|
RU2128042C1 |
3-OR-DI-(2-CHLOROETHYL)-AMINO-CONTAINING II α-ACYL-(HYDR)- -OXYSTEROIDS SHOWING ANTITUMOR ACTIVITY | 1998 |
|
RU2139292C1 |
METHOD OF PREPARING COMPLEX OF 1-(2'-HYDROXYETHYL)-2-METHYL-5-NITROIMIDAZOLE WITH POLYVINYLPYRROLIDONE | 2001 |
|
RU2205841C2 |
COMPLEX OF 1-(2-HYDROXYETHYL)-2-METHYL-5-NITROIMIDAZOLE WITH POLYVINYLPYRROLIDONE, METHOD OF ITS PREPARING AND PHARMACEUTICAL COMPOSITION SHOWING ANTIBACTERIAL EFFECT | 1998 |
|
RU2157384C2 |
ANTI-TUMOUR PREPARATION | 2014 |
|
RU2569729C1 |
Authors
Dates
1998-05-27—Published
1995-06-28—Filed